ANG Lifesciences India Ltd

ANG Lifesciences Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

ANG Lifesciences India Ltd

₹ 25.4 -4.79%
06 Feb 3:44 p.m.
anglifesciences.com BSE: 540694
About

Incorporated in 2006, ANG Lifesciences India Ltd manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials[1]

Key Points

Business Overview:[1][2]
Company manufactures and sells products like injections, tablets, capsules, syrups, ointments of different varieties. It deals in 4 market segments: institutional segment, third party manufacturing, direct marketing and export market. Apart from this, company is also providing printing & packing solutions especially in mono cartons, paper printing, corrugation, aluminiumfoils (blister foils)

Website BSE
  • Market Cap ₹ 33.2 Cr.
  • Current Price ₹ 25.4
  • High / Low ₹ 42.5 / 21.0
  • Stock P/E
  • Book Value ₹ 50.0
  • Dividend Yield 0.00 %
  • ROCE -3.54 %
  • ROE -13.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.50 times its book value

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -6.58% over past five years.
  • Company has a low return on equity of -7.31% over last 3 years.
  • Promoters have pledged 44.9% of their holding.
  • Earnings include an other income of Rs.1.10 Cr.
  • Company has high debtors of 264 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
58.39 45.17 31.88 50.61 29.58 17.10 34.08 16.18 32.16 23.91 17.67 24.53 25.97
49.15 43.03 43.48 44.94 28.26 18.82 30.23 18.11 29.70 25.89 18.03 22.67 23.75
Operating Profit 9.24 2.14 -11.60 5.67 1.32 -1.72 3.85 -1.93 2.46 -1.98 -0.36 1.86 2.22
OPM % 15.82% 4.74% -36.39% 11.20% 4.46% -10.06% 11.30% -11.93% 7.65% -8.28% -2.04% 7.58% 8.55%
0.20 0.32 9.20 0.34 0.33 -0.09 -1.49 1.36 0.36 -0.03 0.75 0.17 0.21
Interest 3.20 2.84 1.11 1.94 1.96 1.99 3.44 1.67 1.87 1.71 2.05 1.61 1.59
Depreciation 1.90 1.92 2.82 1.94 1.97 2.02 1.83 1.51 1.62 1.84 1.30 1.45 1.45
Profit before tax 4.34 -2.30 -6.33 2.13 -2.28 -5.82 -2.91 -3.75 -0.67 -5.56 -2.96 -1.03 -0.61
Tax % 39.63% -30.43% -20.54% 25.35% -10.09% -20.96% 23.71% -26.13% 61.19% -17.99% -34.46% -23.30% 29.51%
2.62 -1.60 -5.03 1.60 -2.05 -4.59 -3.60 -2.77 -1.07 -4.57 -1.94 -0.79 -0.80
EPS in Rs 2.02 -1.23 -3.85 1.23 -1.57 -3.52 -2.76 -2.12 -0.82 -3.50 -1.49 -0.60 -0.61
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
34.50 36.84 54.92 66.93 75.13 121.27 126.08 154.24 348.52 206.82 131.30 89.73 92.08
29.61 33.72 50.19 60.43 67.83 109.63 113.65 138.91 282.98 195.15 121.75 90.75 90.34
Operating Profit 4.89 3.12 4.73 6.50 7.30 11.64 12.43 15.33 65.54 11.67 9.55 -1.02 1.74
OPM % 14.17% 8.47% 8.61% 9.71% 9.72% 9.60% 9.86% 9.94% 18.81% 5.64% 7.27% -1.14% 1.89%
0.12 0.09 0.21 0.25 0.69 0.23 0.42 0.75 0.95 9.84 -0.89 1.99 1.10
Interest 1.51 1.66 1.66 1.77 1.85 2.64 3.22 3.98 8.31 10.92 9.77 7.64 6.96
Depreciation 3.05 0.95 1.06 1.17 1.19 1.12 1.23 2.24 5.12 8.52 7.75 6.27 6.04
Profit before tax 0.45 0.60 2.22 3.81 4.95 8.11 8.40 9.86 53.06 2.07 -8.86 -12.94 -10.16
Tax % 55.56% 31.67% 25.23% 25.98% 24.65% 30.33% 27.50% 26.47% 25.18% 131.88% -2.48% -20.02%
0.19 0.40 1.65 2.82 3.72 5.65 6.10 7.25 39.71 -0.66 -8.65 -10.34 -8.10
EPS in Rs 0.21 0.43 1.79 3.07 2.86 4.35 4.69 5.58 30.55 -0.51 -6.62 -7.92 -6.20
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.61% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 9%
5 Years: -7%
3 Years: -36%
TTM: -7%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 24%
Stock Price CAGR
10 Years: %
5 Years: -3%
3 Years: -35%
1 Year: -37%
Return on Equity
10 Years: 12%
5 Years: 9%
3 Years: -7%
Last Year: -14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 3.68 3.68 3.68 3.68 5.18 5.18 5.18 5.18 10.37 13.06 13.06 13.06 13.06
Reserves -0.97 -0.57 1.09 3.81 17.99 23.58 29.37 36.17 73.11 72.48 64.01 53.75 52.20
11.03 10.15 11.77 14.01 17.42 21.90 20.83 42.40 60.99 55.56 59.36 70.58 78.12
11.44 12.59 18.95 25.34 27.57 30.24 38.69 58.49 124.21 111.40 81.00 71.28 80.68
Total Liabilities 25.18 25.85 35.49 46.84 68.16 80.90 94.07 142.24 268.68 252.50 217.43 208.67 224.06
9.04 8.78 9.02 8.90 9.47 20.60 20.94 21.89 82.32 78.68 53.35 52.63 49.79
CWIP 0.00 0.00 0.00 0.07 11.57 0.16 0.23 0.40 0.00 0.00 0.00 0.00 0.00
Investments 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 3.52 3.52 3.52 3.52 3.52
16.12 17.05 26.45 37.85 47.10 60.12 72.88 119.93 182.84 170.30 160.56 152.52 170.75
Total Assets 25.18 25.85 35.49 46.84 68.16 80.90 94.07 142.24 268.68 252.50 217.43 208.67 224.06

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
3.58 3.13 1.86 2.73 0.88 7.46 4.83 -11.18 27.39 26.01 -13.13 -2.29
-2.14 -2.32 -2.92 -2.56 -13.40 -0.77 -1.66 -7.79 -42.50 -9.35 20.02 -1.63
-1.43 -0.89 1.63 -0.29 13.10 -3.80 -3.95 18.81 15.29 -16.75 -7.00 3.92
Net Cash Flow 0.02 -0.08 0.56 -0.12 0.57 2.89 -0.77 -0.16 0.17 -0.08 -0.12 -0.01

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 79.67 62.22 108.86 139.39 156.19 125.66 133.34 139.10 103.67 137.85 192.56 264.24
Inventory Days 83.99 84.14 46.81 44.62 53.41 27.18 41.03 67.62 46.29 92.90 143.34 227.95
Days Payable 129.49 129.88 133.28 163.44 153.96 90.63 105.80 158.84 105.16 153.93 243.56 333.86
Cash Conversion Cycle 34.17 16.48 22.39 20.58 55.64 62.21 68.56 47.88 44.80 76.83 92.34 158.34
Working Capital Days 28.25 18.73 10.23 14.40 48.29 39.70 52.60 47.14 22.05 27.88 74.97 71.80
ROCE % 13.65% 16.74% 26.04% 29.34% 21.90% 23.56% 21.92% 19.90% 53.78% 8.51% 1.78% -3.54%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
71.15% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60%
28.85% 29.40% 29.38% 29.41% 29.39% 29.39% 29.39% 29.39% 29.39% 29.39% 29.40% 29.40%
No. of Shareholders 6,9467,1637,3057,0556,9186,8686,6316,4686,5176,5086,4006,273

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls

  • Aug 2022
    Transcript
    AI Summary
    PPT
  • Feb 2022
    Transcript
    AI Summary
    PPT
  • Oct 2021
    Transcript
    AI Summary
    PPT
  • Sep 2021
    Transcript
    AI Summary
    PPT
  • Jun 2019
    Transcript
    AI Summary
    PPT